SYNH Syneos Health, Inc. Stock Quote

SYNH [NASD]

Healthcare | Diagnostics & Research | USA

Index	-	P/E	42.86	EPS (ttm)	1.82	Insider Own	0.40%	Shs Outstand	104.28M	Perf Week	4.56%
Market Cap	8.15B	Forward P/E	18.66	EPS next Y	4.18	Insider Trans	-99.39%	Shs Float	61.17M	Perf Month	16.17%
Income	192.00M	PEG	2.99	EPS next Q	1.10	Inst Own	98.10%	Short Float	8.79%	Perf Quarter	30.67%
Sales	4.49B	P/S	1.82	EPS this Y	467.60%	Inst Trans	-5.07%	Short Ratio	6.79	Perf Half Y	28.05%
Book/sh	29.69	P/B	2.63	EPS next Y	23.05%	ROA	2.60%	Target Price	80.00	Perf Year	22.22%
Cash/sh	2.38	P/C	32.74	EPS next 5Y	14.31%	ROE	6.30%	52W Range	30.02 - 78.22	Perf YTD	14.50%
Dividend	-	P/FCF	19.41	EPS past 5Y	34.80%	ROI	4.90%	52W High	-1.57%	Beta	1.84
Dividend %	-	Quick Ratio	1.10	Sales past 5Y	31.70%	Gross Margin	22.50%	52W Low	156.46%	ATR	2.13
Employees	24000	Current Ratio	1.10	Sales Q/Q	-6.60%	Oper. Margin	6.30%	RSI (14)	72.61	Volatility	2.57% 3.18%
Optionable	Yes	Debt/Eq	0.83	EPS Q/Q	7.10%	Profit Margin	4.30%	Rel Volume	0.28	Prev Close	78.01
Shortable	Yes	LT Debt/Eq	0.81	Earnings	Oct 29 BMO	Payout	0.00%	Avg Volume	791.58K	Price	76.99
Recom	1.80	SMA20	7.67%	SMA50	14.40%	SMA200	28.70%	Volume	85,431	Change	-1.31%

Oct-06-20

Upgrade

Mizuho

Neutral → Buy

$65

Oct-01-20

Upgrade

Goldman

Neutral → Buy

$69 → $75

Mar-30-20

Downgrade

Goldman

Buy → Neutral

$79 → $45

Jan-07-20

Initiated

Citigroup

Buy

$75

Oct-19-18

Upgrade

William Blair

Mkt Perform → Outperform

Oct-09-18

Initiated

UBS

Buy

Oct-04-18

Initiated

Evercore ISI

Outperform

$58

Jan-13-21 04:23AM	Have Insiders Been Buying Syneos Health, Inc. (NASDAQ:SYNH) Shares? Simply Wall St.
Jan-07-21 07:30AM	Why It Might Be Time To Pay Attention To These 3 Red-Hot Health Stocks Investor's Business Daily
07:15AM	Are These Medical Stocks Cruising Toward Bullish Gains? Here's A Key Sign Investor's Business Daily
Jan-04-21 04:15PM	Syneos Health to Present at the 39th Annual J.P. Morgan Healthcare Conference GlobeNewswire
Dec-21-20 08:48AM	Syneos Health (SYNH) Buys Illingworth Research, Expands CRO Base Zacks
Dec-18-20 09:14AM	Syneos Health Acquires Illingworth Research Group, a Leading Provider of Clinical Research Home Health Services GlobeNewswire
04:00AM	Syneos Health, Inc.'s (NASDAQ:SYNH) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects? Simply Wall St.
Dec-16-20 08:08AM	Syneos Health's (SYNH) Shares March Higher, Can It Continue? Zacks
Dec-15-20 10:28AM	Is SYNH A Good Stock To Buy Now? Insider Monkey
Dec-14-20 10:37AM	Billionaire David Shaw Bets Big on These 3 Healthcare Stocks TipRanks
Dec-11-20 09:30AM	Is Syneos Health (SYNH) a Good Value Investor Stock Now? Zacks
Dec-10-20 08:59AM	Syneos Health Completes Acquisition of Synteract GlobeNewswire
Dec-07-20 05:18PM	Syneos Health to Outline Value Creation Plan at 2020 Analyst and Investor Event GlobeNewswire
08:00AM	VBI Vaccines Selects Syneos Health as Commercialization Partner for Prophylactic 3-Antigen Hepatitis B Vaccine Business Wire
Dec-03-20 08:49AM	Syneos Health and ConcertAI Announce Strategic Collaboration to Accelerate the Use of Real World Evidence and AI to Advance Oncology Research GlobeNewswire
Dec-02-20 08:30AM	Syneos Health Announces Pricing of Secondary Offering of Common Stock GlobeNewswire
Dec-01-20 04:21PM	Syneos Health Announces Secondary Offering of Common Stock GlobeNewswire
Nov-30-20 11:42AM	Here's Why You Should Invest in Syneos Health (SYNH) Now Zacks
Nov-25-20 03:36AM	Estimating The Fair Value Of Syneos Health, Inc. (NASDAQ:SYNH) Simply Wall St.
Nov-24-20 06:07PM	Syneos Health Announces Closing of Offering of $600.0 Million of Senior Notes Due 2029 GlobeNewswire
Nov-18-20 06:52PM	Syneos Health Announces Upsizing and Pricing of Offering of $600.0 Million of Senior Notes Due 2029 GlobeNewswire
07:22AM	Syneos Health Announces Senior Notes Offering GlobeNewswire
Nov-17-20 08:40AM	Syneos Health Names Larry A. Pickett Jr. Chief Information & Digital Officer GlobeNewswire
Nov-16-20 08:43AM	Syneos Health to Host Virtual Analyst and Investor Event on December 8, 2020 GlobeNewswire
Nov-12-20 08:56AM	1Life Healthcare (ONEM) in Focus: Stock Moves 6.3% Higher Zacks
Nov-03-20 08:19AM	Syneos Health (SYNH) Q3 Earnings Top Estimates, Margins Up Zacks
Nov-02-20 05:20PM	Syneos Health to Present at Upcoming Investor Conferences GlobeNewswire +5.40%
10:43AM	Syneos Health, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For Next Year Simply Wall St.
Oct-30-20 01:08PM	If You Like EPS Growth Then Check Out Syneos Health (NASDAQ:SYNH) Before It's Too Late Simply Wall St.
Oct-29-20 07:59AM	Syneos Health: Q3 Earnings Insights Benzinga
07:35AM	Syneos Health (SYNH) Tops Q3 Earnings Estimates Zacks
06:13AM	Syneos Health Reports Third Quarter 2020 Results GlobeNewswire
06:00AM	Syneos Health, Inc. to Host Earnings Call ACCESSWIRE
Oct-28-20 05:39PM	Syneos Health to Acquire Synteract, a Top CRO Provider to Emerging Biopharma GlobeNewswire
Oct-22-20 12:33PM	Syneos Health (SYNH) Reports Next Week: Wall Street Expects Earnings Growth Zacks
Oct-21-20 06:30AM	Syneos Health® Launches Kinetic Omnichannel Capability to Accelerate Modern Customer Engagement GlobeNewswire
Oct-19-20 06:30AM	Syneos Health Named to Forbes 2020 List of Worlds Best Employers GlobeNewswire
Oct-13-20 08:45AM	Syneos Health Wins Society for Clinical Research Sites Eagle Award for Fourth Consecutive Year GlobeNewswire
Oct-07-20 11:45AM	Is Syneos Health, Inc. (NASDAQ:SYNH) Potentially Undervalued? Simply Wall St.
Oct-05-20 04:58PM	Syneos Health Schedules Third Quarter 2020 Earnings Call for Thursday, October 29, 2020 GlobeNewswire
Sep-28-20 09:59AM	Syneos Health Banks on Essential Therapies Amid Coronavirus Woe Zacks
Sep-16-20 06:20PM	Analyst Report: Syneos Health, Inc. Morningstar Research -10.23%
04:52PM	Hedge Funds Have Never Been This Bullish On Syneos Health, Inc. (SYNH) Insider Monkey
08:52AM	Syneos Health Announces Pricing of Secondary Offering of Common Stock GlobeNewswire
Sep-15-20 04:51PM	Syneos Health Announces Secondary Offering of Common Stock GlobeNewswire
Sep-10-20 02:42PM	If You Had Bought Syneos Health (NASDAQ:SYNH) Shares Five Years Ago You'd Have Earned25% Returns Simply Wall St.
Sep-09-20 10:55AM	Update: Syneos Health to Present at the Baird 2020 Global Healthcare Conference at 12:15 p.m. ET Today GlobeNewswire
Sep-05-20 11:32AM	Syneos Health (SYNH) Down 8.2% Since Last Earnings Report: Can It Rebound? Zacks
Sep-02-20 07:30AM	Syneos Health to Present at the Baird 2020 Global Healthcare Conference GlobeNewswire
Sep-01-20 08:12AM	Syneos Health-Idorsia Collaborate to Launch Daridorexant in US Zacks
Aug-11-20 09:50AM	Syneos Health (SYNH) Q2 Earnings Top Estimates, Margins Down Zacks
Aug-06-20 09:45AM	Syneos Health (SYNH) Q2 Earnings and Revenues Surpass Estimates Zacks
06:14AM	Syneos Health Reports Second Quarter 2020 Results GlobeNewswire
Jul-30-20 12:33PM	Earnings Preview: Syneos Health (SYNH) Q2 Earnings Expected to Decline Zacks
Jul-20-20 11:02AM	Did Hedge Funds Make The Right Call On Syneos Health, Inc. (SYNH) ? Insider Monkey
Jul-13-20 08:30AM	Syneos Health Signs New Service Agreement With Pfizer GlobeNewswire
Jul-11-20 05:42PM	Notable Insider Buys: Acceleron, Continental And Syneos Health Benzinga
03:46PM	Top Insider Buys Highlight for the Week of July 10 GuruFocus.com
Jul-07-20 08:00AM	Syneos Health Bolsters Communications Leadership Team GlobeNewswire
Jul-01-20 03:37PM	Syneos Health Schedules Second Quarter 2020 Earnings Call for Thursday, August 6, 2020 GlobeNewswire
Jun-22-20 08:42AM	Invitae (NVTA) Looks Good: Stock Adds 5.8% in Session Zacks
Jun-19-20 09:38AM	Senseonics Holdings (SENS) Catches Eye: Stock Jumps 5.7% Zacks
Jun-17-20 01:52PM	Hedge Funds Are Nibbling On Syneos Health, Inc. (SYNH) Insider Monkey
11:08AM	Edited Transcript of SYNH.OQ earnings conference call or presentation 30-Apr-20 12:00pm GMT Thomson Reuters StreetEvents
Jun-16-20 08:43AM	Allscripts (MDRX) Looks Good: Stock Adds 9.1% in Session Zacks
08:39AM	10x Genomics (TXG) Looks Good: Stock Adds 6.2% in Session Zacks
May-30-20 11:31AM	Syneos Health (SYNH) Up 9.3% Since Last Earnings Report: Can It Continue? Zacks
May-28-20 08:30AM	Daiichi Sankyo and Syneos Health® Form Strategic Coalition for Development of Daiichi Sankyos ADC Oncology Pipeline Business Wire
May-22-20 08:39AM	Syneos Health to Present at Upcoming Investor Conferences GlobeNewswire
May-13-20 12:15PM	Syneos Health to Present at the UBS Virtual Global Healthcare Conference GlobeNewswire
May-04-20 10:26AM	Syneos Health (SYNH) Tops Q1 Earnings Estimates, Margins Down Zacks
Apr-30-20 06:00PM	Syneos Health, Inc. (SYNH) Q1 2020 Earnings Call Transcript Motley Fool
07:55AM	Syneos Health (SYNH) Beats Q1 Earnings and Revenue Estimates Zacks
06:34AM	Syneos Health Reports First Quarter 2020 Results GlobeNewswire
Apr-23-20 12:32PM	Syneos Health (SYNH) Reports Next Week: Wall Street Expects Earnings Growth Zacks
Apr-07-20 06:54AM	Syneos Health Provides COVID-19 Business Update GlobeNewswire
Apr-03-20 04:17PM	Syneos Health Responds to COVID-19 Public Health Challenge by Joining Call to Action to Activate Clinically-Qualified Healthcare Professionals GlobeNewswire
Apr-02-20 02:54PM	Gone: Triangle public companies lose $30 billion in value during 1Q 2020 American City Business Journals
Apr-01-20 02:31PM	Triangle firm shines light on alternative to ventilators in battle against COVID-19 American City Business Journals -8.22%
Mar-30-20 12:09PM	Syneos Health Launches Initiative for COVID-19 Patients Zacks
Mar-27-20 05:13PM	Syneos Health Launches Ventilator Initiative to Raise Awareness of Bridging Option to Address Ventilator Shortage for COVID-19 Patients GlobeNewswire -5.28%
10:28AM	Do Hedge Funds Think Syneos Health, Inc. (SYNH) Is A Good Stock To Buy? Insider Monkey
Mar-25-20 07:09AM	Trade Alert: The Chief Financial Officer Of Syneos Health, Inc. (NASDAQ:SYNH), Jason Meggs, Has Just Spent US$131k Buying Shares Simply Wall St. +8.79%
Mar-21-20 11:30AM	Syneos Health (SYNH) Down 49.8% Since Last Earnings Report: Can It Rebound? Zacks
Mar-17-20 09:27AM	What Is Syneos Health's (NASDAQ:SYNH) P/E Ratio After Its Share Price Tanked? Simply Wall St.
Mar-05-20 04:05PM	Edited Transcript of SYNH earnings conference call or presentation 20-Feb-20 1:00pm GMT Thomson Reuters StreetEvents
Feb-28-20 08:41AM	Syneos Health Grows on New Alliances Amid Regulatory Upheavals Zacks
08:07AM	Here's Why You Should Hold Syneos Health in Your Portfolio Now Zacks
Feb-25-20 01:59PM	Did Business Growth Power Syneos Health's (NASDAQ:SYNH) Share Price Gain of 126%? Simply Wall St.
Feb-24-20 02:59PM	Advance Auto Parts, Cree among Triangle companies hit as stocks tumble with rising concern over coronavirus American City Business Journals -5.18%
Feb-21-20 07:46AM	The Daily Biotech Pulse: FDA Approves Baudax Bio's Non-Opioid Pain Drug, Aerie Rallies On Q4 Results, D-Day For Esperion Benzinga
06:43AM	Syneos Health (SYNH) Tops Q4 Earnings and Revenue Estimates Zacks
Feb-20-20 02:46PM	Morrisville giant hauled in $4.75 billion in 2019. It wants to go bigger in 2020. American City Business Journals +7.20%
07:55AM	Syneos Health (SYNH) Surpasses Q4 Earnings and Revenue Estimates Zacks
06:20AM	Syneos Health Reports Fourth Quarter and Full Year 2019 Results GlobeNewswire
06:00AM	Syneos Health, Inc. to Host Earnings Call ACCESSWIRE
Feb-19-20 06:56AM	Booming Triangle sector has nearly 24,500 workers, up 4 percent year-over-year List Insights American City Business Journals
Feb-13-20 12:31PM	Syneos Health (SYNH) Earnings Expected to Grow: What to Know Ahead of Next Week's Release Zacks
Jan-22-20 09:00AM	Syneos Health Schedules Fourth Quarter and Year End 2019 Earnings Call for Thursday, February 20, 2020 GlobeNewswire
Jan-20-20 12:59PM	Is Syneos Health, Inc. (NASDAQ:SYNH) Trading At A 42% Discount? Simply Wall St.

Syneos Health, Inc. operates as an integrated biopharmaceutical solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers various clinical development services spanning Phase I to Phase IV, including full-service global studies, as well as clinical monitoring, investigator recruitment, patient recruitment, data management, and study startup to assist customers with drug development process. The Commercial Solutions segment provides commercialization services, including medication adherence, communications solutions, and consulting services. Its customers include small, mid-sized, and large companies in the pharmaceutical, biotechnology, and medical device industries. Syneos Health, Inc. has a strategic agreement with Daiichi Sankyo, Inc. for the development of Daiichi Sankyo'S Adc oncology pipeline; and a partnership with VBI Vaccines Inc. for the commercialization of VBI's 3-antigen prophylactic hepatitis B vaccine in the United States, Europe, and Canada, which is in pending regulatory approvals. The company was formerly known as INC Research Holdings, Inc. and changed its name to Syneos Health, Inc. in January 2018. Syneos Health, Inc. was incorporated in 2010 and is headquartered in Morrisville, North Carolina.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Meggs Jason M.	Chief Financial Officer	Jan 06	Sale	72.00	5,552	399,744	58,951	Jan 07 05:03 PM
Macdonald Alistair	Chief Executive Officer	Dec 23	Sale	70.52	300	21,155	245,187	Dec 28 05:07 PM
Macdonald Alistair	Chief Executive Officer	Dec 22	Sale	70.02	1,200	84,020	245,487	Dec 28 05:07 PM
ADVENT INTERNATIONAL CORP/MA	10% Owner	Dec 03	Sale	61.28	3,228,241	197,826,608	15,418,795	Dec 07 05:27 PM
Allen Tom	Director	Dec 03	Sale	61.28	3,228,241	197,826,608	15,418,795	Dec 07 05:26 PM
ADVENT INTERNATIONAL CORP/MA	10% Owner	Dec 03	Sale	61.28	3,228,241	197,826,608	15,418,795	Dec 07 05:25 PM
ADVENT INTERNATIONAL CORP/MA	10% Owner	Dec 03	Sale	61.28	3,228,241	197,826,608	15,418,795	Dec 07 05:22 PM
Maldonado John L.	Director	Dec 03	Sale	61.28	3,228,241	197,826,608	15,418,795	Dec 07 05:18 PM
ADVENT INTERNATIONAL CORP/MA	10% Owner	Dec 03	Sale	61.28	3,228,241	197,826,608	15,418,795	Dec 07 05:13 PM
THOMAS H. LEE ADVISORS, LLC	Director	Dec 03	Sale	61.28	2,771,132	169,814,969	13,235,545	Dec 07 05:09 PM
THOMAS H. LEE ADVISORS, LLC	Director	Dec 03	Sale	61.28	627	38,423	831	Dec 07 05:09 PM
ADVENT INTERNATIONAL CORP/MA	10% Owner	Dec 03	Sale	61.28	3,228,241	197,826,608	15,418,795	Dec 07 05:07 PM
THOMAS H. LEE ADVISORS, LLC	Director	Dec 03	Sale	61.28	2,771,132	169,814,969	13,235,545	Dec 07 05:05 PM
THOMAS H. LEE ADVISORS, LLC	Director	Dec 03	Sale	61.28	627	38,423	831	Dec 07 05:05 PM
ADVENT INTERNATIONAL CORP/MA	10% Owner	Dec 03	Sale	61.28	3,228,241	197,826,608	15,418,795	Dec 07 04:53 PM
Meggs Jason M.	Chief Financial Officer	Nov 27	Sale	67.00	4,062	272,154	66,003	Nov 30 05:12 PM
Meggs Jason M.	Chief Financial Officer	Nov 24	Sale	67.00	1,938	129,846	70,065	Nov 25 05:01 PM
KEEFE MICHELLE	Pres., Commercial Solutions	Nov 18	Sale	65.00	856	55,640	48,881	Nov 19 05:00 PM
KEEFE MICHELLE	Pres., Commercial Solutions	Nov 17	Sale	62.65	800	50,120	49,643	Nov 19 05:00 PM
ADVENT INTERNATIONAL CORP/MA	10% Owner	Sep 17	Sale	59.26	3,766,281	223,189,812	18,647,036	Sep 21 09:56 PM
ADVENT INTERNATIONAL CORP/MA	10% Owner	Sep 17	Sale	59.26	3,766,281	223,189,812	18,647,036	Sep 21 09:56 PM
ADVENT INTERNATIONAL CORP/MA	10% Owner	Sep 17	Sale	59.26	3,766,281	223,189,812	18,647,036	Sep 21 09:55 PM
Allen Tom	Director	Sep 17	Sale	59.26	3,766,281	223,189,812	18,647,036	Sep 21 09:55 PM
ADVENT INTERNATIONAL CORP/MA	10% Owner	Sep 17	Sale	59.26	3,766,281	223,189,812	18,647,036	Sep 21 09:55 PM
Maldonado John L.	Director	Sep 17	Sale	59.26	3,766,281	223,189,812	18,647,036	Sep 21 09:54 PM
ADVENT INTERNATIONAL CORP/MA	10% Owner	Sep 17	Sale	59.26	3,766,281	223,189,812	18,647,036	Sep 21 09:54 PM
ADVENT INTERNATIONAL CORP/MA	10% Owner	Sep 17	Sale	59.26	3,766,281	223,189,812	18,647,036	Sep 21 09:53 PM
THOMAS H. LEE ADVISORS, LLC	Director	Sep 17	Sale	59.26	3,232,987	191,586,810	16,006,677	Sep 21 05:39 PM
THOMAS H. LEE ADVISORS, LLC	Director	Sep 17	Sale	59.26	732	43,378	1,005	Sep 21 05:39 PM
THOMAS H. LEE ADVISORS, LLC	Director	Sep 17	Sale	59.26	3,232,987	191,586,810	16,006,677	Sep 21 05:30 PM
THOMAS H. LEE ADVISORS, LLC	Director	Sep 17	Sale	59.26	732	43,378	1,005	Sep 21 05:30 PM
Macdonald Alistair	Chief Executive Officer	Aug 03	Sale	65.07	10,289	669,464	246,687	Aug 04 05:06 PM
Macdonald Alistair	Chief Executive Officer	Jul 15	Option Exercise	16.06	37,868	608,160	280,088	Jul 17 05:03 PM
Macdonald Alistair	Chief Executive Officer	Jul 15	Sale	60.14	37,868	2,277,495	261,154	Jul 17 05:03 PM
Macdonald Alistair	Chief Executive Officer	Jul 14	Option Exercise	10.57	5,173	54,679	266,327	Jul 15 05:03 PM
Macdonald Alistair	Chief Executive Officer	Jul 14	Sale	58.68	5,173	303,553	261,154	Jul 15 05:03 PM
Macdonald Alistair	Chief Executive Officer	Jul 13	Option Exercise	10.57	3,655	38,633	264,809	Jul 15 05:03 PM
Macdonald Alistair	Chief Executive Officer	Jul 13	Sale	58.21	3,655	212,747	261,154	Jul 15 05:03 PM
Dineen John M.	Director	Jul 06	Buy	59.11	8,691	513,725	17,426	Jul 08 05:04 PM
KEEFE MICHELLE	Pres., Commercial Solutions	Jul 06	Sale	59.11	1,500	88,665	50,443	Jul 08 05:06 PM
KEEFE MICHELLE	Pres., Commercial Solutions	May 20	Sale	60.00	2,500	150,000	51,943	May 21 05:01 PM
Parks Robert	EVP, Chief Accounting Officer	Apr 20	Sale	49.65	3,588	178,144	12,450	Apr 21 07:04 PM
Meggs Jason M.	Chief Financial Officer	Mar 20	Buy	36.74	3,555	130,613	63,829	Mar 23 05:04 PM
COLVIN PAUL	Pres., Clinical Solutions	Mar 19	Buy	36.65	1,300	47,645	26,855	Mar 23 05:06 PM
Meggs Jason M.	Chief Financial Officer	Mar 05	Option Exercise	0.00	5,094	0	68,923	Apr 15 06:39 PM
Macdonald Alistair	Chief Executive Officer	Mar 05	Option Exercise	0.00	31,258	0	248,937	Apr 15 06:55 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience